Zotarolimus-eluting stent fracture at initial implantation diagnosed with StentBoost
Stent fracture is a rare complication of drug-eluting stent implantation with a reported rate of 0.84%–3.2% in various clinical studies with first-generation drug-eluting stents and 29% in autopsy studies. Sirolimus-eluting stents with their closed cell design were reported to be more prone to fract...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2016-05-01
|
Series: | SAGE Open Medical Case Reports |
Online Access: | https://doi.org/10.1177/2050313X16645754 |
id |
doaj-6c7cd837fb664ab5858140dc67c7d82d |
---|---|
record_format |
Article |
spelling |
doaj-6c7cd837fb664ab5858140dc67c7d82d2020-11-25T02:34:07ZengSAGE PublishingSAGE Open Medical Case Reports2050-313X2016-05-01410.1177/2050313X1664575410.1177_2050313X16645754Zotarolimus-eluting stent fracture at initial implantation diagnosed with StentBoostAlev Arat OzkanUmit Yasar SinanAziz T GurmenStent fracture is a rare complication of drug-eluting stent implantation with a reported rate of 0.84%–3.2% in various clinical studies with first-generation drug-eluting stents and 29% in autopsy studies. Sirolimus-eluting stents with their closed cell design were reported to be more prone to fracture compared to paclitaxel-eluting stents. Other risk factors for stent fracture are multiple stenting, longer stent length, chronic renal failure, right coronary artery intervention, and a higher maximal inflation pressure. The role of angiography in diagnosing stent fracture is limited, a fact also questioning the reliability of angiographic data. Image enhancement techniques like StentBoost are widely available in new-generation angiography systems and are used to assess stent expansion, overlap size, or to localize the postdilation balloon. Here, we report a case of zotarolimus-eluting stent fracture at initial implantation diagnosed with StentBoost.https://doi.org/10.1177/2050313X16645754 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Alev Arat Ozkan Umit Yasar Sinan Aziz T Gurmen |
spellingShingle |
Alev Arat Ozkan Umit Yasar Sinan Aziz T Gurmen Zotarolimus-eluting stent fracture at initial implantation diagnosed with StentBoost SAGE Open Medical Case Reports |
author_facet |
Alev Arat Ozkan Umit Yasar Sinan Aziz T Gurmen |
author_sort |
Alev Arat Ozkan |
title |
Zotarolimus-eluting stent fracture at initial implantation diagnosed with StentBoost |
title_short |
Zotarolimus-eluting stent fracture at initial implantation diagnosed with StentBoost |
title_full |
Zotarolimus-eluting stent fracture at initial implantation diagnosed with StentBoost |
title_fullStr |
Zotarolimus-eluting stent fracture at initial implantation diagnosed with StentBoost |
title_full_unstemmed |
Zotarolimus-eluting stent fracture at initial implantation diagnosed with StentBoost |
title_sort |
zotarolimus-eluting stent fracture at initial implantation diagnosed with stentboost |
publisher |
SAGE Publishing |
series |
SAGE Open Medical Case Reports |
issn |
2050-313X |
publishDate |
2016-05-01 |
description |
Stent fracture is a rare complication of drug-eluting stent implantation with a reported rate of 0.84%–3.2% in various clinical studies with first-generation drug-eluting stents and 29% in autopsy studies. Sirolimus-eluting stents with their closed cell design were reported to be more prone to fracture compared to paclitaxel-eluting stents. Other risk factors for stent fracture are multiple stenting, longer stent length, chronic renal failure, right coronary artery intervention, and a higher maximal inflation pressure. The role of angiography in diagnosing stent fracture is limited, a fact also questioning the reliability of angiographic data. Image enhancement techniques like StentBoost are widely available in new-generation angiography systems and are used to assess stent expansion, overlap size, or to localize the postdilation balloon. Here, we report a case of zotarolimus-eluting stent fracture at initial implantation diagnosed with StentBoost. |
url |
https://doi.org/10.1177/2050313X16645754 |
work_keys_str_mv |
AT alevaratozkan zotarolimuselutingstentfractureatinitialimplantationdiagnosedwithstentboost AT umityasarsinan zotarolimuselutingstentfractureatinitialimplantationdiagnosedwithstentboost AT aziztgurmen zotarolimuselutingstentfractureatinitialimplantationdiagnosedwithstentboost |
_version_ |
1724810015343116288 |